State Street Corporation has acquired a 4.8% stake in REGENXBIO Inc., signaling increased institutional interest in the biological products sector.
| Name | REGENXBIO Inc. |
|---|---|
| CIK | 0001590877 |
| Tickers | RGNX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 471851754 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | — |
| Phone | 240-552-8181 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
State Street Corporation has acquired a 4.8% stake in REGENXBIO Inc., signaling increased institutional interest in the biological products sector.
REGENXBIO Inc. has released its Q3 report, showcasing growth in its biological products and advancements in gene therapy.
REGENXBIO Inc. announces its financial results for Q3 2026, showcasing ongoing challenges in the biological products sector.
REGENXBIO Inc.'s Chief Strategy & Legal Officer, Patrick J. Christmas, acquires 34,722 shares, signaling ongoing executive compensation strategies.
REGENXBIO Inc. announces the resignation of Kenneth T. Mills from its board, with George Migausky stepping in as Chairman. This reflects ongoing changes in the industry.
806 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-10 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000715 | 005-89108 | 261538331 | 34 | 8224 | |||
| 2026-11-05 | 10-Q | 10-Q | 0001193125-26-448581 | 001-37553 | 261524782 | 34 | 15334792 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-448559 | 001-37553 | 261524739 | 34 | 529054 | 1 | 1 |
| 2026-11-03 | 4 | PRIMARY DOCUMENT | 0002062007-26-000007 | 5361 | ||||||
| 2026-11-03 | 4 | PRIMARY DOCUMENT | 0001521123-26-000010 | 5365 | ||||||
| 2026-11-03 | 4 | PRIMARY DOCUMENT | 0001700659-26-000018 | 5356 | ||||||
| 2026-11-03 | 4 | PRIMARY DOCUMENT | 0001789335-26-000010 | 5379 | ||||||
| 2026-10-16 | 8-K | 8-K | 5.02 | 0001193125-26-423376 | 001-37553 | 261464319 | 34 | 147797 | 1 | 1 |
| 2026-10-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000019617-26-000350 | 005-89108 | 261456261 | 34 | 6791 | |||
| 2026-09-23 | 8-K | 8-K | 1.01 | 0001193125-26-399377 | 001-37553 | 261401069 | 34 | 149897 | 1 | 1 |
| 2026-09-03 | 4 | PRIMARY DOCUMENT | 0002062007-26-000005 | 5364 | ||||||
| 2026-09-03 | 4 | PRIMARY DOCUMENT | 0001789335-26-000008 | 5385 | ||||||
| 2026-08-27 | 4 | PRIMARY DOCUMENT | 0002023732-26-000008 | 11813 | ||||||
| 2026-08-27 | 3 | PRIMARY DOCUMENT | 0002023732-26-000007 | 6825 | ||||||
| 2026-08-25 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-365287 | 001-37553 | 261316620 | 34 | 203373 | 1 | 1 |
| 2026-08-24 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-363786 | 001-37553 | 261311621 | 34 | 206280 | 1 | 1 |
| 2026-08-06 | 10-Q | 10-Q | 0001193125-26-336725 | 001-37553 | 261245962 | 34 | 15527783 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-336716 | 001-37553 | 261245945 | 34 | 574068 | 1 | 1 |
| 2026-08-04 | 4 | PRIMARY DOCUMENT | 0001700659-26-000016 | 8696 | ||||||
| 2026-08-04 | 4 | PRIMARY DOCUMENT | 0001521123-26-000008 | 5364 | ||||||
| 2026-07-20 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-308342 | 001-37553 | 261185172 | 34 | 495424 | 1 | 1 |
| 2026-07-17 | 424B5 | 424B5 | 0001193125-26-308027 | 333-291816 | 261184665 | 33 | 678385 | |||
| 2026-07-17 | FWP | FWP | 0001193125-26-306576 | 333-291816 | 261181745 | 34 | 80744 | |||
| 2026-07-16 | 424B5 | 424B5 | 0001193125-26-306170 | 333-291816 | 261180726 | 33 | 649811 | |||
| 2026-07-06 | 4 | PRIMARY DOCUMENT | 0001346164-26-000006 | 9461 | ||||||
| 2026-07-06 | 4 | PRIMARY DOCUMENT | 0001700659-26-000014 | 9182 | ||||||
| 2026-07-06 | SC TO-I/A | SC TO-I/A | 0001193125-26-295587 | 005-89108 | 261154310 | 34 | 39921 | |||
| 2026-07-01 | 4 | PRIMARY DOCUMENT | 0001700659-26-000012 | 11214 | ||||||
| 2026-07-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006719 | 001-37553 | 261145708 | 33 | 6565 | |||
| 2026-07-01 | SC TO-I/A | SC TO-I/A | 0001193125-26-291681 | 005-89108 | 261142930 | 34 | 98645 | |||
| 2026-06-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-286825 | 001-37553 | 261131300 | 34 | 213785 | 1 | 1 |
| 2026-06-04 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000019617-26-000236 | 005-89108 | 261064039 | 34 | 7213 | |||
| 2026-06-03 | SC TO-I | SC TO-I | 0001193125-26-254638 | 005-89108 | 261058977 | 34 | 11982156 | |||
| 2026-06-03 | 8-K | 8-K | 5.07,8.01 | 0001193125-26-254590 | 001-37553 | 261058928 | 34 | 172660 | 1 | 1 |
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0001502785-26-000001 | 7591 | ||||||
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0001191235-26-000003 | 7468 | ||||||
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0001737231-26-000002 | 7601 | ||||||
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0001652824-26-000003 | 7609 | ||||||
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0001134365-26-000001 | 7605 | ||||||
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0001191229-26-000002 | 7520 | ||||||
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0001658390-26-000001 | 7619 | ||||||
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0001652936-26-000001 | 10941 | ||||||
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0001872219-26-000001 | 7603 | ||||||
| 2026-05-14 | 10-Q | 10-Q | 0001193125-26-222804 | 001-37553 | 26975853 | 34 | 12763951 | 1 | 1 | |
| 2026-05-14 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001193125-26-222768 | 001-37553 | 26975816 | 34 | 976710 | 1 | 1 |
| 2026-05-13 | 4 | PRIMARY DOCUMENT | 0001700659-26-000010 | 5601 | ||||||
| 2026-05-12 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000286 | 005-89108 | 26966967 | 34 | 8252 | |||
| 2026-05-11 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004334 | 001-37553 | 26963840 | 33 | 5763 | |||
| 2026-04-14 | ARS | ARS | 0001193125-26-155100 | 001-37553 | 26861645 | 34 | 2562649 | |||
| 2026-04-14 | DEFA14A | DEFA14A | 0001193125-26-155070 | 001-37553 | 26861534 | 34 | 1260172 | |||
| 2026-04-14 | DEF 14A | DEF 14A | 0001193125-26-155058 | 001-37553 | 26861499 | 34 | 4603334 | 1 | 1 | |
| 2026-04-03 | PRE 14A | PRE 14A | 0001193125-26-142245 | 001-37553 | 26838513 | 34 | 4603596 | 1 | 1 | |
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-002154 | 005-89108 | 26803188 | 34 | 7250 | |||
| 2026-03-20 | 8-K | 8-K | 1.01 | 0001193125-26-117913 | 001-37553 | 26779157 | 34 | 147706 | 1 | 1 |
| 2026-03-12 | 4 | PRIMARY DOCUMENT | 0001700659-26-000008 | 5002 | ||||||
| 2026-03-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-002438 | 001-37553 | 26739883 | 33 | 4888 | |||
| 2026-03-05 | 10-K | 10-K | 0001193125-26-094013 | 001-37553 | 26726432 | 34 | 20476288 | 1 | 1 | |
| 2026-03-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-092566 | 001-37553 | 26724197 | 34 | 552271 | 1 | 1 |
| 2026-02-12 | 424B5 | 424B5 | 0001193125-26-048688 | 333-291816 | 26626115 | 33 | 576175 | |||
| 2026-02-10 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-043342 | 001-37553 | 26613269 | 34 | 208153 | 1 | 1 |
| 2026-02-03 | 4 | PRIMARY DOCUMENT | 0001521123-26-000006 | 5229 | ||||||
| 2026-02-03 | 4 | PRIMARY DOCUMENT | 0001700659-26-000006 | 5220 | ||||||
| 2026-01-29 | 4 | PRIMARY DOCUMENT | 0001652824-26-000002 | 9330 | ||||||
| 2026-01-28 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-026139 | 001-37553 | 26568544 | 34 | 205215 | 1 | 1 |
| 2026-01-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-26-000190 | 005-89108 | 26545741 | 34 | 10984 | |||
| 2026-01-08 | 4 | PRIMARY DOCUMENT | 0001700659-26-000004 | 7672 | ||||||
| 2026-01-08 | 4 | PRIMARY DOCUMENT | 0002062007-26-000003 | 7676 | ||||||
| 2026-01-08 | 4 | PRIMARY DOCUMENT | 0001346164-26-000004 | 7681 | ||||||
| 2026-01-08 | 4 | PRIMARY DOCUMENT | 0001521123-26-000004 | 7681 | ||||||
| 2026-01-08 | 4 | PRIMARY DOCUMENT | 0001789335-26-000002 | 7695 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0001346164-26-000002 | 5301 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0002062007-26-000002 | 5283 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0001521123-26-000002 | 5287 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0001700659-26-000003 | 5296 | ||||||
| 2025-12-12 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003711 | 333-291816 | 251569882 | 33 | 1884 | ||
| 2025-12-09 | CORRESP | filename1.htm | 0001193125-25-312817 | 6638 | ||||||
| 2025-11-26 | S-3 | S-3 | 0001193125-25-300539 | 333-291816 | 251530456 | 33 | 622357 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-268101 | 001-37553 | 251456198 | 34 | 533431 | 1 | 1 |
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-268095 | 001-37553 | 251456164 | 34 | 13834678 | 1 | 1 | |
| 2025-10-10 | 4 | PRIMARY DOCUMENT | 0001346164-25-000005 | 5470 | ||||||
| 2025-10-09 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007868 | 001-37553 | 251385290 | 33 | 6400 | |||
| 2025-10-01 | 4 | PRIMARY DOCUMENT | 0001346164-25-000003 | 5469 | ||||||
| 2025-09-12 | 4 | PRIMARY DOCUMENT | 0001562180-25-006194 | 5469 | ||||||
| 2025-09-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-006948 | 001-37553 | 251306311 | 33 | 5127 | |||
| 2025-09-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-006079 | 5225 | ||||||
| 2025-09-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-006078 | 5245 | ||||||
| 2025-08-18 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-109829 | 001-37553 | 251228787 | 34 | 207120 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-078638 | 005-89108 | 251219516 | 34 | 18881 | |||
| 2025-08-07 | 10-Q | 10-Q | 0001193125-25-174953 | 001-37553 | 251191608 | 34 | 15205900 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 1.01,2.02,7.01,9.01 | 0001193125-25-174947 | 001-37553 | 251191573 | 34 | 616419 | 1 | 1 |
| 2025-08-04 | 4 | PRIMARY DOCUMENT | 0001562180-25-005618 | 5227 | ||||||
| 2025-07-15 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002222 | 005-89108 | 251125553 | 34 | 10933 | |||
| 2025-07-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-005334 | 5219 | ||||||
| 2025-06-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002024 | 333-288053 | 251074971 | 33 | 1884 | ||
| 2025-06-25 | 424B3 | 424B3 | 0001193125-25-146911 | 333-288053 | 251073793 | 33 | 254019 | |||
| 2025-06-23 | CORRESP | filename1.htm | 0001193125-25-144857 | 7186 | ||||||
| 2025-06-20 | UPLOAD | filename1.pdf | 0000000000-25-006467 | 333-288053 | 40153 | |||||
| 2025-06-13 | S-3 | S-3 | 0001193125-25-140870 | 333-288053 | 251047726 | 33 | 429558 | |||
| 2025-06-13 | S-8 | S-8 | 0000950170-25-086259 | 333-288040 | 251047105 | 33 | 450554 | |||
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-004355 | 10802 | ||||||
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-004354 | 7461 | ||||||
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-004353 | 7451 | ||||||
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-004352 | 7328 | ||||||
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-004351 | 7472 | ||||||
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-004350 | 7465 | ||||||
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-004349 | 7479 | ||||||
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-004348 | 7340 | ||||||
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-004347 | 7463 | ||||||
| 2025-06-03 | 8-K | 8-K | 5.07 | 0000950170-25-080986 | 001-37553 | 251020082 | 34 | 173169 | 1 | 1 |
| 2025-05-19 | 8-K | 8-K | 1.01,2.03,7.01,9.01 | 0001193125-25-122456 | 001-37553 | 25964087 | 34 | 175432 | 1 | 1 |
| 2025-05-14 | 4 | PRIMARY DOCUMENT | 0001562180-25-003822 | 9467 | ||||||
| 2025-05-12 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-002911 | 001-37553 | 25935294 | 33 | 4894 | |||
| 2025-05-12 | 10-Q | 10-Q | 0000950170-25-069237 | 001-37553 | 25935049 | 34 | 12781680 | 1 | 1 | |
| 2025-05-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-069211 | 001-37553 | 25934927 | 34 | 472839 | 1 | 1 |
| 2025-04-24 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-001546 | 005-89108 | 25863857 | 34 | 10935 | |||
| 2025-04-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001101 | 333-269086 | 25837450 | 33 | 1896 | ||
| 2025-04-08 | ARS | ARS | 0000950170-25-052088 | 001-37553 | 25822293 | 34 | 1809928 | |||
| 2025-04-08 | DEFA14A | DEFA14A | 0000950170-25-052082 | 001-37553 | 25822222 | 34 | 1266104 | |||
| 2025-04-08 | DEF 14A | DEF 14A | 0000950170-25-052069 | 001-37553 | 25822120 | 34 | 11528802 | 1 | 1 | |
| 2025-04-04 | 4 | PRIMARY DOCUMENT | 0001562180-25-003010 | 5213 | ||||||
| 2025-04-04 | 4 | PRIMARY DOCUMENT | 0001562180-25-003009 | 5218 | ||||||
| 2025-04-04 | 4 | PRIMARY DOCUMENT | 0001562180-25-003008 | 5223 | ||||||
| 2025-03-31 | 4 | PRIMARY DOCUMENT | 0001562180-25-002804 | 7337 | ||||||
| 2025-03-24 | 3 | PRIMARY DOCUMENT | 0001562180-25-002709 | 14655 | ||||||
| 2025-03-13 | S-8 | S-8 | 0000950170-25-038862 | 333-285797 | 25736682 | 33 | 163072 | |||
| 2025-03-13 | POS AM | POS AM | 0001193125-25-053998 | 333-269086 | 25736561 | 33 | 2005163 | |||
| 2025-03-13 | 10-K | 10-K | 0000950170-25-038770 | 001-37553 | 25736077 | 34 | 22871093 | 1 | 1 | |
| 2025-03-13 | POSASR | POSASR | 0001193125-25-053917 | 333-269086 | 25735881 | 33 | 2074570 | |||
| 2025-03-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-038711 | 001-37553 | 25735701 | 34 | 519630 | 1 | 1 |
| 2025-03-04 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-045585 | 001-37553 | 25704264 | 34 | 164462 | 1 | 1 |
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000019617-25-000259 | 005-89108 | 25614385 | 34 | 6860 | |||
| 2025-02-05 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000093751-25-000088 | 005-89108 | 25590931 | 34 | 8077 | |||
| 2025-01-31 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000211 | 005-89108 | 25576314 | 34 | 6372 | |||
| 2025-01-14 | 4/A | PRIMARY DOCUMENT | 0001562180-25-000360 | 6153 | ||||||
| 2025-01-14 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-25-005659 | 001-37553 | 25527747 | 34 | 178990 | 1 | 1 |
| 2025-01-08 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-000047 | 005-89108 | 25519635 | 34 | 44857 | |||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-25-000190 | 9608 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-25-000189 | 9610 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-25-000188 | 9613 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-25-000187 | 9180 | ||||||
| 2025-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-25-000186 | 7748 | ||||||
| 2024-12-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-010094 | 001-37553 | 241589838 | 33 | 4910 | |||
| 2024-12-09 | 424B5 | 424B5 | 0001193125-24-273517 | 333-269086 | 241535974 | 33 | 527182 | 1 | 1 | |
| 2024-12-09 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-273467 | 001-37553 | 241535656 | 34 | 497806 | 1 | 1 |
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119431 | 005-89108 | 241465542 | 34 | 107916 | |||
| 2024-11-12 | SC 13G/A | UnitedStates_13G__REGENXBIOI.txt | 0000932471-24-001135 | 005-89108 | 241449319 | 34 | 6675 | |||
| 2024-11-06 | 10-Q | 10-Q | 0000950170-24-122330 | 001-37553 | 241431157 | 34 | 10333170 | 1 | 1 | |
| 2024-11-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-122300 | 001-37553 | 241431007 | 34 | 435962 | 1 | 1 |
| 2024-11-04 | SC 13G/A | UnitedStates_13G__REGENXBIOI.txt | 0000932471-24-000670 | 005-89108 | 241422382 | 34 | 5752 | |||
| 2024-10-17 | SC 13G/A | FILING REGENXBIO INC. | 0000019617-24-000592 | 005-89108 | 34 | 90052 | ||||
| 2024-10-02 | 4 | PRIMARY DOCUMENT | 0001562180-24-007144 | 9288 | ||||||
| 2024-09-18 | 4 | PRIMARY DOCUMENT | 0001562180-24-006869 | 8045 | ||||||
| 2024-09-18 | 3 | PRIMARY DOCUMENT | 0001562180-24-006868 | 6742 | ||||||
| 2024-09-17 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-24-107367 | 001-37553 | 241305169 | 34 | 213975 | 1 | 1 |
| 2024-09-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-006657 | 11277 | ||||||
| 2024-08-12 | 4 | PRIMARY DOCUMENT | 0001562180-24-006146 | 7990 | ||||||
| 2024-08-06 | 8-K | 8-K | 5.02 | 0001193125-24-194111 | 001-37553 | 241176436 | 34 | 140491 | 1 | 1 |
| 2024-08-05 | 4 | PRIMARY DOCUMENT | 0001562180-24-006017 | 5230 | ||||||
| 2024-08-05 | 4 | PRIMARY DOCUMENT | 0001562180-24-006016 | 5224 | ||||||
| 2024-08-05 | 4 | PRIMARY DOCUMENT | 0001562180-24-006015 | 16699 | ||||||
| 2024-08-05 | 4 | PRIMARY DOCUMENT | 0001562180-24-006014 | 5043 | ||||||
| 2024-08-05 | 4 | PRIMARY DOCUMENT | 0001562180-24-006013 | 7316 | ||||||
| 2024-08-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-005776 | 001-37553 | 241167326 | 33 | 6458 | |||
| 2024-08-01 | 10-Q | 10-Q | 0000950170-24-089320 | 001-37553 | 241167037 | 34 | 10266033 | 1 | 1 | |
| 2024-08-01 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-089278 | 001-37553 | 241166709 | 34 | 437029 | 1 | 1 |
| 2024-07-30 | 4 | PRIMARY DOCUMENT | 0001562180-24-005875 | 9235 | ||||||
| 2024-07-30 | 4 | PRIMARY DOCUMENT | 0001562180-24-005874 | 5476 | ||||||
| 2024-07-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-005640 | 001-37553 | 241152493 | 33 | 5134 | |||
| 2024-07-26 | 4 | PRIMARY DOCUMENT | 0001562180-24-005855 | 15142 | ||||||
| 2024-07-18 | 4 | PRIMARY DOCUMENT | 0001562180-24-005798 | 14705 | ||||||
| 2024-07-03 | 4 | PRIMARY DOCUMENT | 0001562180-24-005567 | 8017 | ||||||
| 2024-07-03 | 4 | PRIMARY DOCUMENT | 0001562180-24-005566 | 9309 | ||||||
| 2024-07-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-005142 | 001-37553 | 241091289 | 33 | 5014 | |||
| 2024-06-13 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-24-160146 | 001-37553 | 241039844 | 34 | 179119 | 1 | 1 |
| 2024-06-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-004656 | 7447 | ||||||
| 2024-06-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-004655 | 7473 | ||||||
| 2024-06-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-004654 | 7348 | ||||||
| 2024-06-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-004653 | 7487 | ||||||
| 2024-06-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-004652 | 7471 | ||||||
| 2024-06-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-004651 | 10810 | ||||||
| 2024-06-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-004650 | 7459 | ||||||
| 2024-06-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-004649 | 7336 | ||||||
| 2024-06-03 | 8-K | 8-K | 5.07,9.01 | 0000950170-24-068050 | 001-37553 | 241014200 | 34 | 162348 | 1 | 1 |
| 2024-05-16 | 4 | PRIMARY DOCUMENT | 0001562180-24-004104 | 9528 | ||||||
| 2024-05-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-003648 | 001-37553 | 24944738 | 33 | 6643 | |||
| 2024-05-08 | 10-Q | 10-Q | 0000950170-24-055691 | 001-37553 | 24926318 | 34 | 9060599 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-055656 | 001-37553 | 24926111 | 34 | 392396 | 1 | 1 |
| 2024-04-17 | 4 | PRIMARY DOCUMENT | 0001562180-24-003452 | 9527 | ||||||
| 2024-04-04 | ARS | ARS | 0000950170-24-041819 | 001-37553 | 24823364 | 34 | 1915602 | |||
| 2024-04-04 | DEFA14A | DEFA14A | 0000950170-24-041814 | 001-37553 | 24823307 | 34 | 1209199 | |||
| 2024-04-04 | DEF 14A | DEF 14A | 0000950170-24-041805 | 001-37553 | 24823253 | 34 | 5815586 | 1 | 1 | |
| 2024-03-21 | 4 | PRIMARY DOCUMENT | 0001562180-24-002907 | 7328 | ||||||
| 2024-03-18 | 4 | PRIMARY DOCUMENT | 0001562180-24-002771 | 9528 | ||||||
| 2024-03-11 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-064353 | 001-37553 | 24736578 | 34 | 527408 | 1 | 1 |
| 2024-03-08 | 424B5 | 424B5 | 0001193125-24-062813 | 333-269086 | 24732252 | 33 | 530974 | |||
| 2024-03-07 | 4 | PRIMARY DOCUMENT | 0001562180-24-002430 | 12434 | ||||||
| 2024-03-07 | FWP | FWP | 0001193125-24-061273 | 333-269086 | 24728015 | 34 | 78697 | |||
| 2024-03-06 | 424B5 | 424B5 | 0001193125-24-060745 | 333-269086 | 24726225 | 33 | 489309 | |||
| 2024-03-05 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-001869 | 001-37553 | 24720917 | 33 | 5622 | |||
| 2024-02-27 | S-8 | S-8 | 0000950170-24-021296 | 333-277412 | 24687949 | 33 | 129762 | |||
| 2024-02-27 | 10-K | 10-K | 0000950170-24-021161 | 001-37553 | 24686937 | 34 | 17870185 | 1 | 1 | |
| 2024-02-27 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-021130 | 001-37553 | 24686771 | 34 | 443273 | 1 | 1 |
| 2024-02-16 | 4 | PRIMARY DOCUMENT | 0001562180-24-001395 | 11488 | ||||||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023775 | 005-89108 | 24638931 | 34 | 104918 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021818 | 005-89108 | 24629460 | 34 | 13159 | |||
| 2024-02-05 | SC 13G/A | SC 13G/A | 0001140361-24-005627 | 005-89108 | 24595380 | 34 | 57200 | |||
| 2024-01-25 | SC 13G/A | FILING REGENXBIO INC. | 0000019617-24-000155 | 005-89108 | 34 | 90067 | ||||
| 2024-01-25 | SC 13G/A | FILING REGENXBIO INC. | 0000019617-24-000144 | 005-89108 | 34 | 90067 | ||||
| 2024-01-25 | SC 13G/A | REGENXBIO_Inc.txt | 0000093751-24-000190 | 005-89108 | 24558568 | 34 | 8631 | |||
| 2024-01-19 | SC 13G/A | us75901b1070_011924.txt | 0001086364-24-000398 | 005-89108 | 24545224 | 34 | 13603 | |||
| 2024-01-18 | 4 | PRIMARY DOCUMENT | 0001562180-24-000544 | 9496 | ||||||
| 2024-01-16 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000307 | 001-37553 | 24535445 | 33 | 5703 | |||
| 2024-01-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-000257 | 9602 | ||||||
| 2024-01-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-000252 | 11687 | ||||||
| 2024-01-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-000249 | 13697 | ||||||
| 2024-01-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-000246 | 9595 | ||||||
| 2024-01-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-000223 | 9596 | ||||||
| 2024-01-04 | 4 | PRIMARY DOCUMENT | 0001562180-24-000219 | 9582 | ||||||
| 2024-01-03 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000131 | 001-37553 | 24506786 | 33 | 4897 | |||
| 2023-12-21 | 4 | PRIMARY DOCUMENT | 0001562180-23-008519 | 13511 | ||||||
| 2023-12-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-006320 | 001-37553 | 231497727 | 33 | 4979 | |||
| 2023-11-17 | SC 13G | SC 13G | 0001104659-23-119604 | 005-89108 | 231419907 | 34 | 96916 | |||
| 2023-11-08 | 10-Q | 10-Q | 0000950170-23-061144 | 001-37553 | 231388091 | 34 | 11790222 | 1 | 1 | |
| 2023-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-061110 | 001-37553 | 231387915 | 34 | 533089 | 1 | 1 |
| 2023-09-01 | 424B5 | 424B5 | 0001193125-23-227707 | 333-269086 | 231233122 | 33 | 418653 | |||
| 2023-09-01 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-227647 | 001-37553 | 231232650 | 34 | 401644 | 1 | 1 |
| 2023-08-04 | S-3ASR | S-3ASR | 0001193125-23-203922 | 333-273727 | 231144485 | 33 | 250789 | |||
| 2023-08-02 | 10-Q | 10-Q | 0000950170-23-037178 | 001-37553 | 231135809 | 34 | 12603004 | 1 | 1 | |
| 2023-08-02 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-037162 | 001-37553 | 231135673 | 34 | 608293 | 1 | 1 |
| 2023-06-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-004896 | 14043 | ||||||
| 2023-06-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-004894 | 10697 | ||||||
| 2023-06-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-004893 | 7253 | ||||||
| 2023-06-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-004892 | 10754 | ||||||
| 2023-06-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-004891 | 10774 | ||||||
| 2023-06-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-004890 | 7265 | ||||||
| 2023-06-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-004889 | 10728 | ||||||
| 2023-06-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-004888 | 10716 | ||||||
| 2023-06-05 | 8-K | 8-K | 5.07,9.01 | 0000950170-23-026437 | 001-37553 | 23993798 | 34 | 189129 | 1 | 1 |
| 2023-06-02 | 4 | PRIMARY DOCUMENT | 0001562180-23-004722 | 11583 | ||||||
| 2023-05-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-058100 | 005-89108 | 23904714 | 34 | 13070 | |||
| 2023-05-03 | 10-Q | 10-Q | 0000950170-23-017200 | 001-37553 | 23884212 | 34 | 10823281 | 1 | 1 | |
| 2023-05-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-017184 | 001-37553 | 23883842 | 34 | 551819 | 1 | 1 |
| 2023-04-07 | SC 13G | SC 13G | 0001140361-23-017270 | 005-89108 | 23808244 | 34 | 56087 | |||
| 2023-04-06 | ARS | ARS | 0000950170-23-012081 | 001-37553 | 23806465 | 34 | 1271818 | |||
| 2023-04-06 | DEFA14A | DEFA14A | 0000950170-23-012078 | 001-37553 | 23806359 | 34 | 934050 | |||
| 2023-04-06 | DEF 14A | DEF 14A | 0000950170-23-012070 | 001-37553 | 23806277 | 34 | 5774347 | 1 | 1 | |
| 2023-02-28 | S-8 | S-8 | 0000950170-23-005157 | 333-270116 | 23686233 | 33 | 172074 | |||
| 2023-02-28 | 10-K | 10-K | 0000950170-23-005085 | 001-37553 | 23685384 | 34 | 21189065 | 1 | 1 | |
| 2023-02-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-005077 | 001-37553 | 23685254 | 34 | 665455 | 1 | 1 |
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-016830 | 005-89108 | 23604151 | 34 | 13077 | |||
| 2023-02-03 | SC 13G/A | REGENXBIO_Inc.txt | 0000093751-23-000151 | 005-89108 | 23584867 | 34 | 8578 | |||
| 2023-01-27 | SC 13G/A | FILING REGENXBIO INC. | 0000019617-23-000166 | 005-89108 | 34 | 89856 | ||||
| 2023-01-23 | SC 13G/A | us75901b1070_012323.txt | 0001306550-23-002197 | 005-89108 | 23544216 | 34 | 13346 | |||
| 2023-01-10 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-005019 | 001-37553 | 23519604 | 34 | 166744 | 1 | 1 |
| 2023-01-05 | 4 | PRIMARY DOCUMENT | 0001562180-23-000224 | 9460 | ||||||
| 2023-01-05 | 4 | PRIMARY DOCUMENT | 0001562180-23-000223 | 9466 | ||||||
| 2023-01-05 | 4 | PRIMARY DOCUMENT | 0001562180-23-000222 | 11554 | ||||||
| 2023-01-05 | 4 | PRIMARY DOCUMENT | 0001562180-23-000220 | 9457 | ||||||
| 2023-01-05 | 4 | PRIMARY DOCUMENT | 0001562180-23-000221 | 9460 | ||||||
| 2023-01-05 | 4 | PRIMARY DOCUMENT | 0001562180-23-000219 | 9446 | ||||||
| 2022-12-30 | S-3ASR | S-3ASR | 0001193125-22-315441 | 333-269086 | 221502168 | 33 | 424305 | |||
| 2022-11-03 | 10-Q | 10-Q | 0000950170-22-021567 | 001-37553 | 221356320 | 34 | 12818390 | 1 | 1 | |
| 2022-11-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-021548 | 001-37553 | 221356231 | 34 | 651306 | 1 | 1 |
| 2022-08-31 | 4 | PRIMARY DOCUMENT | 0001562180-22-006398 | 5362 | ||||||
| 2022-08-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-005938 | 6890 | ||||||
| 2022-08-03 | 4 | PRIMARY DOCUMENT | 0001562180-22-005876 | 5362 | ||||||
| 2022-08-03 | 10-Q | 10-Q | 0001564590-22-027764 | 001-37553 | 221132707 | 34 | 11503587 | 1 | 1 | |
| 2022-08-03 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-027754 | 001-37553 | 221132545 | 34 | 579452 | 1 | 1 |
| 2022-07-15 | 4 | PRIMARY DOCUMENT | 0001562180-22-005681 | 6894 | ||||||
| 2022-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-22-004883 | 7382 | ||||||
| 2022-06-07 | 3 | PRIMARY DOCUMENT | 0001562180-22-004882 | 6610 | ||||||
| 2022-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-22-004881 | 7334 | ||||||
| 2022-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-22-004880 | 7211 | ||||||
| 2022-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-22-004879 | 7348 | ||||||
| 2022-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-22-004878 | 7223 | ||||||
| 2022-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-22-004876 | 7362 | ||||||
| 2022-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-22-004875 | 7346 | ||||||
| 2022-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-22-004873 | 7346 | ||||||
| 2022-06-07 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-22-168821 | 001-37553 | 22999804 | 34 | 171417 | 1 | 1 |
| 2022-05-04 | 10-Q | 10-Q | 0001564590-22-017878 | 001-37553 | 22892068 | 34 | 10043798 | 1 | 1 | |
| 2022-05-04 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-017853 | 001-37553 | 22891631 | 34 | 506592 | 1 | 1 |
| 2022-04-07 | DEFA14A | DEFA14A | 0001564590-22-013846 | 001-37553 | 22814021 | 34 | 1206815 | |||
| 2022-04-07 | DEF 14A | DEF 14A | 0001564590-22-013843 | 001-37553 | 22813967 | 34 | 2040075 | |||
| 2022-03-25 | 8-K | 8-K | 1.01 | 0001193125-22-085244 | 001-37553 | 22772067 | 34 | 143251 | 1 | 1 |
| 2022-03-18 | 8-K | 8-K | 5.02 | 0001193125-22-079590 | 001-37553 | 22753254 | 34 | 139331 | 1 | 1 |
| 2022-03-01 | S-8 | S-8 | 0001564590-22-008117 | 333-263182 | 22699881 | 33 | 116483 | |||
| 2022-03-01 | 10-K | 10-K | 0001564590-22-008055 | 001-37553 | 22698502 | 34 | 18796787 | 1 | 1 | |
| 2022-03-01 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-008037 | 001-37553 | 22698106 | 34 | 641752 | 1 | 1 |
| 2022-02-14 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-023155 | 005-89108 | 22634483 | 34 | 75604 | |||
| 2022-02-14 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-22-039357 | 001-37553 | 22625134 | 34 | 178657 | 1 | 1 |
| 2022-02-11 | SC 13G/A | REGENXBIO_INC.txt | 0000093751-22-000332 | 005-89108 | 22622864 | 34 | 8554 | |||
| 2022-02-11 | SC 13G/A | SC 13G/A | 0001193125-22-034960 | 005-89108 | 22616351 | 34 | 38186 | |||
| 2022-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-018439 | 005-89108 | 22610678 | 34 | 13072 | |||
| 2022-02-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-22-032205 | 001-37553 | 22605186 | 34 | 221607 | 1 | 1 |
| 2022-01-27 | SC 13G/A | us75901b1070_012722.txt | 0000834237-22-002685 | 005-89108 | 22564271 | 34 | 13370 | |||
| 2022-01-26 | SC 13G/A | us75901b1070_012622.txt | 0000834237-22-001268 | 005-89108 | 22556095 | 34 | 13370 | |||
| 2022-01-24 | 4 | PRIMARY DOCUMENT | 0001562180-22-000597 | 8242 | ||||||
| 2022-01-18 | SC 13G/A | FILING REGENXBIO INC. | 0000019617-22-000112 | 005-89108 | 34 | 89991 | ||||
| 2022-01-04 | 4 | PRIMARY DOCUMENT | 0001562180-22-000170 | 7565 | ||||||
| 2022-01-04 | 4 | PRIMARY DOCUMENT | 0001562180-22-000168 | 9062 | ||||||
| 2022-01-04 | 4 | PRIMARY DOCUMENT | 0001562180-22-000159 | 11140 | ||||||
| 2022-01-04 | 4 | PRIMARY DOCUMENT | 0001562180-22-000156 | 13159 | ||||||
| 2022-01-04 | 4 | PRIMARY DOCUMENT | 0001562180-22-000155 | 9041 | ||||||
| 2022-01-04 | 4 | PRIMARY DOCUMENT | 0001562180-22-000149 | 9056 | ||||||
| 2021-12-27 | 4 | PRIMARY DOCUMENT | 0001562180-21-007876 | 12205 | ||||||
| 2021-12-06 | 4 | PRIMARY DOCUMENT | 0001562180-21-007473 | 4949 | ||||||
| 2021-11-15 | 8-K | 8-K | 1.01 | 0001193125-21-328962 | 001-37553 | 211406396 | 34 | 141248 | 1 | 1 |
| 2021-11-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-21-328180 | 001-37553 | 211404248 | 34 | 183886 | 1 | 1 |
| 2021-11-10 | 4 | PRIMARY DOCUMENT | 0001562180-21-006967 | 8922 | ||||||
| 2021-11-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-21-324463 | 001-37553 | 211392292 | 34 | 165592 | 1 | 1 |
| 2021-11-09 | SC 13G/A | FILING REGENXBIO INC. | 0000019617-21-000473 | 005-89108 | 34 | 90011 | ||||
| 2021-11-02 | 10-Q | 10-Q | 0001564590-21-053565 | 001-37553 | 211371513 | 34 | 13020407 | 1 | 1 | |
| 2021-11-02 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-053557 | 001-37553 | 211371422 | 34 | 658874 | 1 | 1 |
| 2021-10-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-21-296140 | 001-37553 | 211316642 | 34 | 179955 | 1 | 1 |
| 2021-10-01 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-21-289652 | 001-37553 | 211298783 | 34 | 185577 | 1 | 1 |
| 2021-09-29 | 4 | PRIMARY DOCUMENT | 0001562180-21-006147 | 8922 | ||||||
| 2021-09-21 | 4 | FORM 4 SUBMISSION | 0000899243-21-036773 | 8566 | ||||||
| 2021-09-15 | 4 | PRIMARY DOCUMENT | 0001562180-21-005947 | 19335 | ||||||
| 2021-09-13 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-21-270811 | 001-37553 | 211248556 | 34 | 208209 | 1 | 1 |
| 2021-09-08 | 4 | PRIMARY DOCUMENT | 0001562180-21-005879 | 5581 | ||||||
| 2021-09-08 | 4 | PRIMARY DOCUMENT | 0001562180-21-005878 | 5579 | ||||||
| 2021-09-08 | 3 | PRIMARY DOCUMENT | 0001562180-21-005877 | 6650 | ||||||
| 2021-09-08 | 3 | PRIMARY DOCUMENT | 0001562180-21-005876 | 6618 | ||||||
| 2021-09-07 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-265999 | 001-37553 | 211238247 | 34 | 168080 | 1 | 1 |
| 2021-08-09 | 10-Q | 10-Q | 0001564590-21-042652 | 001-37553 | 211156722 | 34 | 10783593 | 1 | 1 | |
| 2021-08-09 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-042634 | 001-37553 | 211156590 | 34 | 600807 | 1 | 1 |
| 2021-07-29 | 4 | PRIMARY DOCUMENT | 0001562180-21-005088 | 8243 | ||||||
| 2021-07-16 | 8-K | 8-K | 8.01 | 0001193125-21-216928 | 001-37553 | 211094259 | 34 | 147228 | 1 | 1 |
| 2021-06-28 | 4 | PRIMARY DOCUMENT | 0001562180-21-004525 | 14624 | ||||||
| 2021-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-21-004131 | 5481 | ||||||
| 2021-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-21-004130 | 5358 | ||||||
| 2021-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-21-004129 | 5370 | ||||||
| 2021-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-21-004127 | 5509 | ||||||
| 2021-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-21-004126 | 5493 | ||||||
| 2021-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-21-004125 | 5477 | ||||||
| 2021-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-21-004122 | 5494 | ||||||
| 2021-06-07 | 8-K | 8-K | 5.03,5.07,9.01 | 0001564590-21-031957 | 001-37553 | 21999734 | 34 | 230355 | 1 | 1 |
| 2021-05-05 | 10-Q | 10-Q | 0001564590-21-024116 | 001-37553 | 21893839 | 34 | 9348147 | 1 | 1 | |
| 2021-05-05 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-024099 | 001-37553 | 21893692 | 34 | 527958 | 1 | 1 |
| 2021-04-19 | DEFA14A | DEFA14A | 0001564590-21-019424 | 001-37553 | 21834981 | 34 | 267716 | |||
| 2021-04-19 | DEF 14A | DEF 14A | 0001564590-21-019415 | 001-37553 | 21834787 | 34 | 3052522 | |||
| 2021-04-08 | PRE 14A | PRE 14A | 0001564590-21-018177 | 001-37553 | 21815099 | 34 | 3053557 | |||
| 2021-03-29 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000994 | 274759 | ||||||
| 2021-03-01 | 4 | PRIMARY DOCUMENT | 0001562180-21-001682 | 9651 | ||||||
| 2021-03-01 | S-8 | S-8 | 0001564590-21-009914 | 333-253725 | 21698801 | 33 | 97713 | |||
| 2021-03-01 | 10-K | 10-K | 0001564590-21-009855 | 001-37553 | 21697831 | 34 | 20610520 | 1 | 1 | |
| 2021-03-01 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-009847 | 001-37553 | 21697723 | 34 | 642935 | 1 | 1 |
| 2021-03-01 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000612 | 276491 | ||||||
| 2021-02-17 | 4 | PRIMARY DOCUMENT | 0001562180-21-001215 | 9418 | ||||||
| 2021-02-16 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-023938 | 005-89108 | 21638273 | 34 | 71525 | |||
| 2021-02-16 | SC 13G/A | REGENXBIO_INC.txt | 0000093751-21-000428 | 005-89108 | 21633013 | 34 | 8565 | |||
| 2021-02-12 | SC 13G/A | SC 13G/A | 0001193125-21-041637 | 005-89108 | 21628049 | 34 | 38865 | |||
| 2021-02-12 | SC 13G/A | SC 13G/A | 0001193125-21-041576 | 48108 | ||||||
| 2021-02-12 | SC 13G/A | SC 13G/A | 0001193125-21-041544 | 005-89108 | 21627580 | 34 | 126917 | |||
| 2021-02-10 | 4 | PRIMARY DOCUMENT | 0001562180-21-001045 | 9419 | ||||||
| 2021-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-018971 | 005-89108 | 21611871 | 34 | 13975 | |||
| 2021-02-04 | 4 | PRIMARY DOCUMENT | 0001562180-21-000913 | 11410 | ||||||
| 2021-01-27 | 4 | PRIMARY DOCUMENT | 0001562180-21-000562 | 14088 | ||||||
| 2021-01-26 | SC 13G/A | us75901b1070_012621.txt | 0000834237-21-001277 | 005-89108 | 21553191 | 34 | 13419 | |||
| 2021-01-20 | 4 | PRIMARY DOCUMENT | 0001562180-21-000379 | 5402 | ||||||
| 2021-01-15 | SC 13G | FILING REGENXBIO INC. | 0000019617-21-000085 | 005-89108 | 34 | 89935 | ||||
| 2021-01-14 | 4 | PRIMARY DOCUMENT | 0001562180-21-000345 | 18775 | ||||||
| 2021-01-14 | 4 | PRIMARY DOCUMENT | 0001562180-21-000344 | 6974 | ||||||
| 2021-01-12 | 4 | PRIMARY DOCUMENT | 0001562180-21-000307 | 28803 | ||||||
| 2021-01-11 | 4 | PRIMARY DOCUMENT | 0001562180-21-000284 | 9428 | ||||||
| 2021-01-11 | 4 | PRIMARY DOCUMENT | 0001562180-21-000283 | 11371 | ||||||
| 2021-01-11 | 4 | PRIMARY DOCUMENT | 0001562180-21-000282 | 10113 | ||||||
| 2021-01-08 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-005232 | 001-37553 | 21517728 | 34 | 365414 | 1 | 1 |
| 2021-01-08 | 424B5 | 424B5 | 0001193125-21-005221 | 333-226691 | 21517691 | 33 | 1284089 | |||
| 2021-01-06 | 424B5 | 424B5 | 0001193125-21-003198 | 333-226691 | 21511075 | 33 | 1281880 | |||
| 2021-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-21-000144 | 7610 | ||||||
| 2021-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-21-000143 | 7617 | ||||||
| 2021-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-21-000142 | 7604 | ||||||
| 2021-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-21-000141 | 11695 | ||||||
| 2021-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-21-000140 | 7597 | ||||||
| 2021-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-21-000139 | 7610 | ||||||
| 2021-01-05 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-21-001959 | 001-37553 | 21505686 | 34 | 220165 | 1 | 1 |
| 2020-12-30 | 4 | PRIMARY DOCUMENT | 0001562180-20-007506 | 12102 | ||||||
| 2020-12-28 | 4 | PRIMARY DOCUMENT | 0001562180-20-007470 | 6933 | ||||||
| 2020-12-28 | 4 | PRIMARY DOCUMENT | 0001562180-20-007469 | 9652 | ||||||
| 2020-12-22 | 8-K | 8-K | 1.01,2.03,9.01 | 0001193125-20-324578 | 001-37553 | 201408323 | 34 | 177468 | 1 | 1 |
| 2020-12-18 | 4 | PRIMARY DOCUMENT | 0001562180-20-007351 | 9656 | ||||||
| 2020-12-14 | 4 | PRIMARY DOCUMENT | 0001562180-20-007250 | 7395 | ||||||
| 2020-12-14 | 4 | PRIMARY DOCUMENT | 0001562180-20-007249 | 9652 | ||||||
| 2020-11-04 | 10-Q | 10-Q | 0001564590-20-050485 | 001-37553 | 201286886 | 34 | 12120479 | 1 | 1 | |
| 2020-11-04 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-050477 | 001-37553 | 201286842 | 34 | 587673 | 1 | 1 |
| 2020-10-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-277495 | 001-37553 | 201262032 | 34 | 166911 | 1 | 1 |
| 2020-09-18 | 4 | FORM 4 SUBMISSION | 0000899243-20-025725 | 14515 | ||||||
| 2020-09-18 | SC 13D/A | SC 13D/A | 0001193125-20-249155 | 005-89108 | 201184325 | 34 | 53770 | |||
| 2020-08-06 | 10-Q | 10-Q | 0001564590-20-037775 | 001-37553 | 201082009 | 34 | 9956870 | 1 | 1 | |
| 2020-08-06 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-037734 | 001-37553 | 201081695 | 34 | 567836 | 1 | 1 |
| 2020-07-17 | 4 | PRIMARY DOCUMENT | 0001562180-20-005162 | 9435 | ||||||
| 2020-07-02 | 8-K | 8-K | 5.02,9.01 | 0001193125-20-185954 | 001-37553 | 201007241 | 34 | 149786 | 1 | 1 |
| 2020-06-02 | 4 | PRIMARY DOCUMENT | 0001562180-20-004071 | 5519 | ||||||
| 2020-06-02 | 4 | PRIMARY DOCUMENT | 0001562180-20-004070 | 5396 | ||||||
| 2020-06-02 | 4 | PRIMARY DOCUMENT | 0001562180-20-004069 | 5409 | ||||||
| 2020-06-02 | 4 | PRIMARY DOCUMENT | 0001562180-20-004066 | 5547 | ||||||
| 2020-06-02 | 4 | PRIMARY DOCUMENT | 0001562180-20-004065 | 5552 | ||||||
| 2020-06-02 | 4 | PRIMARY DOCUMENT | 0001562180-20-004064 | 5536 | ||||||
| 2020-06-02 | 4 | PRIMARY DOCUMENT | 0001562180-20-004063 | 5515 |
One latest value per concept from companyfacts (344 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 66.12M | 2026-10-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 385.01M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 3.86M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-14 | 0001193125-26-155058 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.92M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-14 | 0001193125-26-155058 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 63.49 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-14 | 0001193125-26-155058 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 2,639.65 | 2026-06-03 | SC TO-I | 2026-06-03 | 0001193125-26-254638 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 2,639.65 | 2026-06-03 | SC TO-I | 2026-06-03 | 0001193125-26-254638 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-06-03 | SC TO-I | 2026-06-03 | 0001193125-26-254638 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-06-03 | SC TO-I | 2026-06-03 | 0001193125-26-254638 | |||
| ffd | TtlTxValtn | TtlTxValtn | USD | 19.11M | 2026-06-03 | SC TO-I | 2026-06-03 | 0001193125-26-254638 | |||
| us-gaap | AccountsAndNotesReceivableNet | Accounts and Financing Receivable, after Allowance for Credit Loss | USD | 8.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 13.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AccountsReceivableGrossCurrent | Accounts Receivable, before Allowance for Credit Loss, Current | USD | 42.88M | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001564590-20-037775 | |
| us-gaap | AccountsReceivableGrossNoncurrent | Accounts Receivable, before Allowance for Credit Loss, Noncurrent | USD | 23.01M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004920 | |
| us-gaap | AccountsReceivableNet | Accounts Receivable, after Allowance for Credit Loss | USD | 8.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 8.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AccountsReceivableNetNoncurrent | Accounts Receivable, after Allowance for Credit Loss, Noncurrent | USD | 450,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 1.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 11.32M | 2021-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005085 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 1.73M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-05 | 0001193125-15-367340 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 96.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.38B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 25.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 1.61M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 25.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 0 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-008055 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 4.59M | 2023-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038770 | |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 13.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 2.10M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | Assets | Assets | USD | 466.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 320.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 306.27M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-08 | 0001564590-18-020194 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 3,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 188,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 155.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AvailableForSaleEquitySecuritiesGrossUnrealizedGain | Available-for-sale Equity Securities, Gross Unrealized Gain | USD | 31.78M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 |
| us-gaap | AvailableForSaleEquitySecuritiesGrossUnrealizedLoss | Available-for-sale Equity Securities, Gross Unrealized Loss | USD | 12.20M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001564590-20-022890 |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 163.91M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 2,000 | 2017-12-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 468,000 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 164.38M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses | Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Loss (Deprecated 2018-01-31) | USD | 144,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31) | USD | 468,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | USD | 61.12M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009855 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss (Deprecated 2018-01-31) | USD | 324,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | USD | 61.12M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009855 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | USD | 12.42M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 155.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedGainLossNet | Available-for-sale Securities, Gross Realized Gain (Loss) | USD | 7.08M | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001564590-20-037775 |
| us-gaap | AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 | Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions | Security | 54 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 | |
| us-gaap | BilledContractReceivables | Billed Contracts Receivable | USD | 2.80M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001193125-26-222804 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 330,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | CapitalizedContractCostImpairmentLoss | Capitalized Contract Cost, Impairment Loss | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 95.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 21.82M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 251.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 97.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 97.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 25.21M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 61.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 22.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 100.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 66.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 66.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 7,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -108.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ContractWithCustomerAssetNetCurrent | Contract with Customer, Asset, after Allowance for Credit Loss, Current | USD | 372,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 22.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 5.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 16.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 111.39M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 16.30M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 | |
| us-gaap | CostMethodInvestments | Cost Method Investments | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001564590-17-003576 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 33.57M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038770 |
| us-gaap | CostOfGoodsSold | Cost of Goods Sold (Deprecated 2018-01-31) | USD | 6,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 213.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 3,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038770 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | -152,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038770 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | -152,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038770 |
| us-gaap | CustomerAdvancesCurrent | Customer Advances, Current | USD | 127,000 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001564590-17-003576 | |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 1.39M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 193,000 | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-08 | 0001564590-17-016550 |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 24.14M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 81,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 125.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 188,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001193125-26-222804 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedGainLoss | Debt Securities, Available-for-sale, Unrealized Gain (Loss) | USD | -358,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 125.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 188,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | Security | 33 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 157,000 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | -284,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-008055 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | -467,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-008055 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 33.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 600,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038770 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 1.10M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 600,000 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001564590-18-028054 | |
| us-gaap | DeferredRevenueRevenueRecognized1 | Deferred Revenue, Revenue Recognized | USD | 7.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | -183,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-008055 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 407.43M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 77.15M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 33.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 184.53M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 94.87M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent | USD | 495,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other | USD | 7.32M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross | Deferred Tax Assets, Unrealized Losses on Available-for-Sale Securities, Gross | USD | 101,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 374.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 398,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-008055 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 1.21M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities | Deferred Tax Liabilities, Unrealized Gains on Trading Securities | USD | 163,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-008055 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 3.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 11.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | DueFromRelatedPartiesCurrent | Due from Related Parties, Current | USD | 5.00M | 2021-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005085 | |
| us-gaap | DueFromRelatedPartiesNoncurrent | Due from Related Parties, Noncurrent | USD | 4.26M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-03 | 0000950170-23-017200 | |
| us-gaap | DueToOtherRelatedPartiesClassifiedCurrent | Due to Other Related Parties, Current | USD | 3.76M | 2014-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 1.42M | 2014-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.9 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.79 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0001564590-22-017878 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.9 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.208 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.007 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.028 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.039 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 16.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 45.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 26.00M | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-08 | 0001564590-17-016550 | |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 0.2 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-008055 | |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009855 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009855 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 5.85M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | FinancingReceivableAllowanceForCreditLosses | Financing Receivable, Allowance for Credit Loss | USD | 4.94M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0000950170-24-122330 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | -100,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | ForeignCurrencyTransactionGainLossUnrealized | Foreign Currency Transaction Gain (Loss), Unrealized | USD | 2,000 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001564590-16-028642 |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | 2.21M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061144 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 63.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ImpairmentOfInvestments | Other than Temporary Impairment Losses, Investments | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004920 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 2.10M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -193.79M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -193.88M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | -83,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 904,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 285,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 280,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 40.42M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -40.71M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 1.14M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 5.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -16,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeTaxReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount | USD | 27,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 7.49M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | IncreaseDecreaseInAccountsPayableRelatedParties | Increase (Decrease) in Accounts Payable, Related Parties | USD | -34,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | -6.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -19.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 758,000 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-05 | 0001193125-15-367340 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -9.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -600,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040403 |
| us-gaap | IncreaseDecreaseInCustomerAdvances | Increase (Decrease) in Customer Advances | USD | -127,000 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -7.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | IncreaseDecreaseInDueFromRelatedPartiesCurrent | Increase (Decrease) in Due from Related Parties, Current | USD | -750,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 |
| us-gaap | IncreaseDecreaseInDueToOtherRelatedPartiesCurrent | Increase (Decrease) in Due to Other Related Parties, Current | USD | -3.76M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | 35.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 687,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 1.35M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001564590-19-030100 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | -163,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 1.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | 225,000 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | IncreaseDecreaseInUnbilledReceivables | Increase (Decrease) in Unbilled Receivables | USD | -327,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 |
| us-gaap | InterestExpense | Interest Expense | USD | 2.42M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-01 | 0000950170-24-089320 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 23.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 7,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 5.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 5.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | LeaseCost | Lease, Cost | USD | 13.87M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 97.24M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 50.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 12.24M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 8.13M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 8.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 7.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 10.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 594,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040403 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 23.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | Liabilities | Liabilities | USD | 318.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 466.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | LiabilitiesAssumed1 | Liabilities Assumed | USD | 265,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-008055 |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 67.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | LicenseAndMaintenanceRevenue | License and Maintenance Revenue (Deprecated 2018-01-31) | USD | 920,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | LicenseAndServicesRevenue | License and Services Revenue (Deprecated 2018-01-31) | USD | 1.20M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | LicenseCosts | License Costs (Deprecated 2018-01-31) | USD | 2.41M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 |
| us-gaap | LicensesRevenue | Licenses Revenue (Deprecated 2018-01-31) | USD | 132.39M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 |
| us-gaap | LitigationReserve | Estimated Litigation Liability | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | LitigationSettlementAmountAwardedFromOtherParty | Litigation Settlement, Amount Awarded from Other Party | USD | 7.50M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038770 |
| us-gaap | LitigationSettlementGain | LitigationSettlementGain | USD | 38.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | LitigationSettlementLoss | LitigationSettlementLoss | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | LossContingencyAccrualProvision | Loss Contingency Accrual, Provision | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | LossContingencyDamagesPaidValue | Loss Contingency, Damages Paid, Value | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 155.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 10.79M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | MarketableSecuritiesRealizedGainLoss | Marketable Securities, Realized Gain (Loss) | USD | 4.80M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005085 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 110.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 4.17M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 50.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -37.09M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -99.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | 58.13M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -108.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -263.49M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021161 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -263.49M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021161 |
| us-gaap | NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification | New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31) | USD | 4.80M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004920 |
| us-gaap | NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 | Noncash or Part Noncash Divestiture, Amount of Consideration Received | USD | 1.12M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-008055 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -18.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | NotesPayableRelatedPartiesClassifiedCurrent | Notes Payable, Related Parties, Current | USD | 2.40M | 2014-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021161 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -89.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 11.26M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 1.40M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0000950170-24-055691 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 73.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 6.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 60.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 13.07M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 42.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 96.54M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 2.80M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004920 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 5.63M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 4.91M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 3.72M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 3.05M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 76.42M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 2.80M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 2.80M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009855 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.057 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 48.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 5.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax | USD | 3.69M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038770 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -358,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -358,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax | USD | 479,000 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-08 | 0001564590-17-022765 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax | USD | -342,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -358,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax | USD | 500,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001564590-20-006826 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 475,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | OtherNoncashExpense | Other Noncash Expense | USD | 3,000 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 8,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 483,000 | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001564590-16-017818 |
| us-gaap | OtherOperatingIncome | Other Operating Income | USD | 26,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | -117,000 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001564590-20-037775 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 1.36M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-336725 | |
| us-gaap | OtherReceivableAfterAllowanceForCreditLossNoncurrent | OtherReceivableAfterAllowanceForCreditLossNoncurrent | USD | 4.15M | 2022-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021161 | |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 4.59M | 2023-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038770 | |
| us-gaap | OtherSalesRevenueNet | Other Revenue, Net (Deprecated 2018-01-31) | USD | 213,000 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061144 |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings | USD | 0 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040403 |
| us-gaap | OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities | Other than Temporary Impairment Losses, Investments, Available-for-sale Securities | USD | 0 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 |
| us-gaap | PaymentsForFees | Payments for Other Fees | USD | 300,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 |
| us-gaap | PaymentsForProceedsFromTenantAllowance | Payments for (Proceeds from) Tenant Allowance | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038770 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 249,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-01 | 0000950170-24-089320 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 138.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 2.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | PreferredStockDividendsAndOtherAdjustments | Preferred Stock Dividends and Other Adjustments | USD | 1.75M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 13.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 107.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 19.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 1.97M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 4.87M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0000950170-25-038770 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 1.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ProceedsFromLegalSettlements | Proceeds from Legal Settlements | USD | 39.00M | 2026-10-01 | 2026-10-31 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 2.40M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001564590-17-003576 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 62,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 179.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 11.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 844,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -108.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | PropertyPlantAndEquipmentAdditions | Property, Plant and Equipment, Additions | USD | 2.30M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005085 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 192.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 95.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | ProvisionForLoanLeaseAndOtherLosses | Provision for Loan, Lease, and Other Losses | USD | -5.00M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | ProvisionForOtherCreditLosses | Provision for Other Credit Losses | USD | -5.00M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | RealizedInvestmentGainsLosses | Realized Investment Gains (Losses) | USD | 16,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 8.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | RedeemableNoncontrollingInterestEquityPreferredCarryingAmount | Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount | USD | 12.59M | 2014-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 | |
| us-gaap | RelatedPartyCosts | Related Party Costs | USD | 861,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001564590-17-003576 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 174.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 1.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 225,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 0 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | RestructuringReservePeriodIncreaseDecrease | Restructuring Reserve, Period Increase (Decrease) | USD | -400,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | RestructuringReserveTranslationAndOtherAdjustment | Restructuring Reserve, Translation and Other Adjustment | USD | -436,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.23B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 123.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 123.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | RevenueFromGrants | Revenue from Grants (Deprecated 2018-01-31) | USD | 8,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | RevenueFromRelatedParties | Revenue from Related Parties | USD | 2.00M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | Revenues | Revenues | USD | 132.39M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011844 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 93,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | SegmentReportingOtherItemAmount | SegmentReportingOtherItemAmount | USD | -19.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 25.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.64 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.043 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 148.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 | |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 111.39M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-06 | 0001564590-18-004532 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 1.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 18.88M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-336725 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 816,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 451,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 4.30M | 2014-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013941 | |
| us-gaap | TradeReceivablesHeldForSaleAmount | Accounts Receivable, Held-for-sale | USD | 609,000 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-05 | 0001193125-15-367340 | |
| us-gaap | UnbilledContractsReceivable | Unbilled Contracts Receivable | USD | 16.50M | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001564590-20-037775 | |
| us-gaap | UnbilledReceivablesCurrent | Unbilled Receivables, Current | USD | 20.11M | 2024-12-31 | 2025 | Q2 | 10-Q | 2025-08-07 | 0001193125-25-174953 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 100,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 36.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 3.06M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-094013 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 52.63M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-336725 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 56.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 42,944 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0001564590-22-017878 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 56.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448581 |